551 Pegasus Skin, a study of SAR444245 (THOR-707, a pegylated recombinant non-alpha IL2) with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers

• Paolo A Ascierto,
• Giovanni Abbadessa,
• Brigitte Demers,
• PARK John,
• Adyb Baakili,
• Rao Saleem,
• Alice Gosselin

Affiliations

Paolo A Ascierto

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

Giovanni Abbadessa

1Sanofi, Cambridge, USA

Brigitte Demers

17Sanofi, Cambridge, MA, USA

PARK John

1Macquarie University, Macquarie, Australia

Adyb Baakili

2Sanofi-Aventis, Vitry-sur-Seine, France

Rao Saleem

3Sanofi, Cambridge, MA, USA

Alice Gosselin

2Sanofi-Aventis, Vitry-sur-Seine, France